These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18953888)

  • 1. [A comparative study on the properties of trichosanthin before and after site-directed PEGylation].
    An QX; Lei YF; Mu SJ; Zhang XQ; Chen R; Xia AJ; Chen C; Yi J; Wu YR; Yu R; Xu ZK
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1433-6. PubMed ID: 18953888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the antigenic determinants and reducing the immunogenicity of trichosanthin by site-directed mutagenesis.
    An Q; Wei S; Mu S; Zhang X; Lei Y; Zhang W; Jia N; Cheng X; Fan A; Li Z; Xu Z
    J Biomed Sci; 2006 Sep; 13(5):637-43. PubMed ID: 16977428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics.
    An Q; Lei Y; Jia N; Zhang X; Bai Y; Yi J; Chen R; Xia A; Yang J; Wei S; Cheng X; Fan A; Mu S; Xu Z
    Biomol Eng; 2007 Dec; 24(6):643-9. PubMed ID: 18023612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed pegylation.
    He XH; Shaw PC; Tam SC
    Life Sci; 1999; 65(4):355-68. PubMed ID: 10421422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed polyethylene glycol modification of trichosanthin: effects on its biological activities, pharmacokinetics, and antigenicity.
    He XH; Shaw PC; Xu LH; Tam SC
    Life Sci; 1999; 64(14):1163-75. PubMed ID: 10210259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction, expression and purification of trichosanthin mutant gene TCS(FYY163-165CSA);].
    Wang Y; Li YH; Liu ZY; Shi Y; Xu ZK; Xu J; Li ZD
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):583-5. PubMed ID: 22691348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro.
    Wang JH; Tam SC; Huang H; Ouyang DY; Wang YY; Zheng YT
    Biochem Biophys Res Commun; 2004 May; 317(4):965-71. PubMed ID: 15094363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y55 and D78 are crucial amino acid residues of a new IgE epitope on trichosanthin.
    Zhang XY; Wu Y; Yan JY; Gao Y; Wang Y; Mi SL; An CC
    Biochem Biophys Res Commun; 2006 May; 343(4):1251-6. PubMed ID: 16581017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and expression of trichosanthin mutant gene TCS(RL28-29CG) and purification of expressed product].
    Wang Y; Shi Y; Liu ZY; Xu ZK; Xu J; Li ZD
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Apr; 27(4):392-4. PubMed ID: 21481314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties.
    Shaw PC; Lee KM; Wong KB
    Toxicon; 2005 May; 45(6):683-9. PubMed ID: 15804517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between trichosanthin, a ribosome-inactivating protein, and the ribosomal stalk protein P2 by chemical shift perturbation and mutagenesis analyses.
    Chan DS; Chu LO; Lee KM; Too PH; Ma KW; Sze KH; Zhu G; Shaw PC; Wong KB
    Nucleic Acids Res; 2007; 35(5):1660-72. PubMed ID: 17308345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independency of anti-HIV-1 activity from ribosome-inactivating activity of trichosanthin.
    Wang JH; Nie HL; Huang H; Tam SC; Zheng YT
    Biochem Biophys Res Commun; 2003 Feb; 302(1):89-94. PubMed ID: 12593852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering of trichosanthin immunogenicity by site-specific coupling to dextran.
    Chan WL; Shaw PC; Li XB; Xu QF; He XH; Tam SC
    Biochem Pharmacol; 1999 Apr; 57(8):927-34. PubMed ID: 10086327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position 120-123, a potential active site of trichosanthin.
    Nie H; Cai X; He X; Xu L; Ke X; Ke Y; Tam SC
    Life Sci; 1998; 62(6):491-500. PubMed ID: 9464461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of trichosanthin antigenicity by coupling to dextran.
    Ko WH; Wong CC; Yeung HW; Tam SC
    Biochem Int; 1992 Dec; 28(4):643-50. PubMed ID: 1282812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity.
    Wang JH; Nie HL; Tam SC; Huang H; Zheng YT
    FEBS Lett; 2002 Nov; 531(2):295-8. PubMed ID: 12417329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the amino acid residues in trichosanthin crucial for IgE response.
    Cai X; Yao G; Xu G; Yang C; Xu H; Lin Y; Yu J; Sun B
    Biochem Biophys Res Commun; 2002 Sep; 297(3):510-6. PubMed ID: 12270124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of epitopes of trichosanthin by phage peptide library.
    Zhu Z; Ming Y; Sun B
    Biochem Biophys Res Commun; 2001 Apr; 282(4):921-7. PubMed ID: 11352639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene cloning, expression and purification of fusion protein epidermal growth factor-linker-trichosanthin].
    Li YM; Yang HW; Luo R
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):205-7. PubMed ID: 17355938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem fusion of albumin-binding domains promoted soluble expression and stability of recombinant trichosanthin in vitro and in vivo.
    Ren Z; Zhao J; Cao X; Wang F
    Protein Expr Purif; 2022 Dec; 200():106147. PubMed ID: 35917982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.